hold glp 1 before surgery How Long Should You Stop GLP-1 Medications Surgery? How GLP‑1 Medications Support Sustainable

Comparative efficacy, safety, and cardiovascular outcomes with once-weekly subcutaneous semaglutide in the treatment of type 2 diabetes: Insights from the PIONEER trials

Factors like starting weight, diet, activity level, metabolic health, and dose all influence the trajectory

Patients who maintain structured eating and regular movement during and after treatment tend to preserve 30 to 50 percent of their initial weight loss for extended periods

Even within the food domain, several methodological issues make summarizing data across studies difficult: studies enrolled small sample sizes, used diverse pharmacological agents (e.g., exenatide, liraglutide, lixisenatide) with different dosing regimens, and mixed acute versus chronic designs

Many patients are surprised to find the scale moving up after starting this medication

GLP-1 receptor agonists (GLP-1-RA) were first developed for the treatment of type-2 diabetes, but have been recently approved for treatment of obesity